• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用来自恰加斯利什曼原虫(利什曼原虫)的半胱氨酸蛋白酶Ldccys1基因和重组Ldccys1蛋白进行免疫接种,可在内脏利什曼病的小鼠模型中引发保护性免疫反应。

Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.

作者信息

Ferreira Josie Haydée L, Gentil Luciana Girotto, Dias Suzana Souza, Fedeli Carlos Eduardo C, Katz Simone, Barbiéri Clara Lúcia

机构信息

Department of Microbiology, Immunology and Parasitology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil.

出版信息

Vaccine. 2008 Jan 30;26(5):677-85. doi: 10.1016/j.vaccine.2007.11.044. Epub 2007 Dec 5.

DOI:10.1016/j.vaccine.2007.11.044
PMID:18160187
Abstract

The gene Ldccys1 encoding a cysteine proteinase of 30 kDa from Leishmania (Leishmania) chagasi, as well as the recombinant cysteine proteinase rLdccys1, obtained by cloning and expression of the Ldccys1 gene in the pHIS vector, were used to evaluate their ability to induce immune protective responses in BALB/c mice against L. (L.) chagasi infection. Mice were immunized subcutaneously with rLdccys1 plus Bacille Calmette Guerin (BCG) or Propionibacterium acnes as adjuvants or intramuscularly with a plasmid carrying the Ldccys1 gene (Ldccys1/pcDNA3) and CpG ODN as the adjuvant, followed by a booster with rLdccys1 plus CpG ODN. Two weeks after immunization the animals were challenged with 1 x 10(7) amastigotes of L. (L.) chagasi. Both immunization protocols induced significant protection against L. (L.) chagasi infection as shown by a very low parasite load in the spleen of immunized mice compared to the non-immunized controls. However, DNA immunization was 10-fold more protective than immunization with the recombinant protein. Whereas rLdccys1 induced a significant secretion of IFN-gamma and nitric oxide (NO), animals immunized with the Ldccys1 gene increased the production of IgG2a antibodies, IFN-gamma and NO. These results indicated that protection triggered by the two immunization protocols was correlated to a predominant Th1 response.

摘要

编码来自恰加斯利什曼原虫(利什曼原虫属)的30 kDa半胱氨酸蛋白酶的基因Ldccys1,以及通过在pHIS载体中克隆和表达Ldccys1基因获得的重组半胱氨酸蛋白酶rLdccys1,被用于评估它们在BALB/c小鼠中诱导针对恰加斯利什曼原虫感染的免疫保护反应的能力。小鼠皮下注射rLdccys1加卡介苗(BCG)或痤疮丙酸杆菌作为佐剂,或肌肉注射携带Ldccys1基因的质粒(Ldccys1/pcDNA3)和CpG ODN作为佐剂,随后用rLdccys1加CpG ODN进行加强免疫。免疫两周后,用1×10⁷个恰加斯利什曼原虫的无鞭毛体攻击动物。与未免疫的对照相比,两种免疫方案均诱导了对恰加斯利什曼原虫感染的显著保护,表现为免疫小鼠脾脏中的寄生虫载量非常低。然而,DNA免疫的保护作用比重组蛋白免疫强10倍。虽然rLdccys1诱导了IFN-γ和一氧化氮(NO)的显著分泌,但用Ldccys1基因免疫的动物增加了IgG2a抗体、IFN-γ和NO的产生。这些结果表明,两种免疫方案引发的保护作用与主要的Th1反应相关。

相似文献

1
Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.用来自恰加斯利什曼原虫(利什曼原虫)的半胱氨酸蛋白酶Ldccys1基因和重组Ldccys1蛋白进行免疫接种,可在内脏利什曼病的小鼠模型中引发保护性免疫反应。
Vaccine. 2008 Jan 30;26(5):677-85. doi: 10.1016/j.vaccine.2007.11.044. Epub 2007 Dec 5.
2
Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.免疫刺激寡脱氧核苷酸是用重组ORFF利什曼原虫抗原免疫的小鼠中保护性免疫的有效增强剂。
Vaccine. 2004 Aug 13;22(23-24):3053-60. doi: 10.1016/j.vaccine.2004.02.007.
3
Successful vaccination against Leishmania chagasi infection in BALB/c mice with freeze-thawed Leishmania antigen and Corynebacterium parvum.用冻融的利什曼原虫抗原和短小棒状杆菌对BALB/c小鼠进行成功的抗恰加斯利什曼原虫感染疫苗接种。
Acta Trop. 2007 Nov-Dec;104(2-3):133-9. doi: 10.1016/j.actatropica.2007.08.007. Epub 2007 Aug 31.
4
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.III型半胱氨酸蛋白酶对BALB/c小鼠的婴儿利什曼原虫感染具有保护作用,并且在内脏利什曼病患者中具有高度抗原性。
Vaccine. 2008 Oct 29;26(46):5822-9. doi: 10.1016/j.vaccine.2008.08.065. Epub 2008 Sep 18.
5
A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi as an antigen for delayed-type hypersensitivity assays and serodiagnosis of canine visceral leishmaniasis.来自恰加斯利什曼原虫(利什曼原虫属)的一种重组半胱氨酸蛋白酶,作为犬内脏利什曼病迟发型超敏反应检测和血清学诊断的抗原。
Vet Parasitol. 2009 May 26;162(1-2):32-9. doi: 10.1016/j.vetpar.2009.02.011. Epub 2009 Feb 14.
6
Co-administration of rectal BCG and autoclaved Leishmania major induce protection in susceptible BALB/c mice.直肠卡介苗和高压灭菌的大沙鼠利什曼原虫共同给药可诱导易感 BALB/c 小鼠产生保护作用。
Parasite Immunol. 2011 Oct;33(10):561-71. doi: 10.1111/j.1365-3024.2011.01318.x.
7
BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice.表达恰加斯利什曼原虫LCR1的卡介苗在易感小鼠中诱导保护性免疫。
Exp Parasitol. 2000 Jan;94(1):33-41. doi: 10.1006/expr.1999.4459.
8
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis.使用婴儿利什曼原虫I型和II型半胱氨酸蛋白酶进行初免-加强免疫接种可赋予小鼠内脏利什曼病保护性免疫。
Vaccine. 2006 Mar 15;24(12):2169-75. doi: 10.1016/j.vaccine.2005.11.011. Epub 2005 Nov 16.
9
Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection.利什曼原虫重组铁超氧化物歧化酶 B1 蛋白在 TLR 佐剂存在的情况下诱导 BALB/c 小鼠对利什曼原虫感染产生部分保护作用。
Exp Parasitol. 2012 Jul;131(3):317-24. doi: 10.1016/j.exppara.2012.05.002. Epub 2012 May 10.
10
Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.用由利什曼原虫主要半胱氨酸蛋白酶I型(CPB)和II型(CPA)组成的混合蛋白疫苗进行免疫接种,可部分预防利什曼病。
Vaccine. 2004 May 7;22(15-16):1930-40. doi: 10.1016/j.vaccine.2003.11.014.

引用本文的文献

1
A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.一种新的免疫化学疗法方案用于仓鼠内脏利什曼病模型。
Parasitol Res. 2022 Oct;121(10):2849-2860. doi: 10.1007/s00436-022-07628-y. Epub 2022 Aug 23.
2
Immunogenic properties of empty pcDNA3 plasmid against zoonotic cutaneous leishmaniasis in mice.空 pcDNA3 质粒对小鼠人兽共患皮肤利什曼病的免疫原性。
PLoS One. 2022 Feb 15;17(2):e0263993. doi: 10.1371/journal.pone.0263993. eCollection 2022.
3
Vaccination in Leishmaniasis: A Review Article.《利什曼病疫苗接种:综述文章》。
Iran Biomed J. 2022 Jan 1;26(1):1-35. doi: 10.52547/ibj.26.1.35.
4
Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule.新型免疫化学疗法方案诱导皮肤利什曼病的保护性细胞免疫应答。
Front Immunol. 2020 Mar 3;11:345. doi: 10.3389/fimmu.2020.00345. eCollection 2020.
5
Treatment of -Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Triggers Protective Cellular Immune Responses.用钯环配合物和热灭活物的组合治疗感染的小鼠可引发保护性细胞免疫反应。
Front Microbiol. 2017 Mar 6;8:333. doi: 10.3389/fmicb.2017.00333. eCollection 2017.
6
Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.表达半胱氨酸蛋白酶和A2基因的重组无致病性利什曼原虫作为实验性犬内脏利什曼病候选疫苗的评估
PLoS One. 2015 Jul 21;10(7):e0132794. doi: 10.1371/journal.pone.0132794. eCollection 2015.
7
Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis.利用重组半胱氨酸蛋白酶从恰加斯利什曼原虫(Leishmania)婴儿用于犬内脏利什曼病的免疫治疗。
PLoS Negl Trop Dis. 2014 Mar 13;8(3):e2729. doi: 10.1371/journal.pntd.0002729. eCollection 2014 Mar.
8
Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis.用利什曼原虫和唾液感染狗作为研究犬内脏利什曼病的模型。
PLoS One. 2013;8(4):e60535. doi: 10.1371/journal.pone.0060535. Epub 2013 Apr 5.
9
Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.沙氏利什曼原虫(Viannia)纯化抗原可提供针对小鼠皮肤利什曼病的保护。
Inflamm Res. 2012 Mar;61(3):255-63. doi: 10.1007/s00011-011-0407-5. Epub 2011 Dec 14.
10
In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate.杜氏利什曼原虫中一种分泌性丝氨酸蛋白酶的原位免疫定位、阶段依赖性表达及其作为候选疫苗的作用
Clin Vaccine Immunol. 2010 Apr;17(4):660-7. doi: 10.1128/CVI.00358-09. Epub 2010 Jan 27.